JAK1 and Alzheimer disease: Our study demonstrated that HLJDT can relieve AD itching symptoms by adjusting GRP, SP, TRPV-1, p-JAK1, HRH4, and IL-4αR expressions in dorsal root ganglion and reducing the release of cytokines, including IL-31.